Epidemiology and treatment of novel coronavirus pneumonia in children and adults
- Author:
Binbin YANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Adult outbreak; Childhood outbreak; Epidemiology; Novel coronavirus; Pneumonia
- From: Journal of Xi'an Jiaotong University(Medical Sciences) 2020;41(4):483-487
- CountryChina
- Language:Chinese
- Abstract: A number of patients with pneumonitis infected by the novel coronavirus (SARS-CoV-2) have been detected since December 2019. The initial reported patients were mainly middle-aged and elderly, and children had low incidence and were not susceptible. As the number of children infected gradually increased, the infection spread to premature babies, infants and young children, and severe cases in children have now occurred. Susceptibility characteristics of the entire population have been identified in the latest diagnosis and treatment plan. At present, the proportion of children affected by the disease is relatively low, but it still deserves enough attention. The epidemiology of novel coronavirus pneumonia in children and adults is unclear, and there is no specific drug for treatment, which brings great difficulties to epidemic prevention and control and clinical treatment. Early identification of epidemiological characteristics and effective treatment with drugs are the key to preventing and controlling this new epidemic. This article analyzes the pathogenic characteristics of SARS-CoV-2, epidemiological characteristics of the epidemic in children and adults, differences in the incidence, and the current status of treatment. Last it explores possible causes and possible effective treatment measures.
